MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-MH-18-0006871
Geltec Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹362.73 Cr
▲ 7% YoY
Net profit · FY 2025
₹38.33 Cr
Net margin 10.6%
EBITDA · FY 2025
₹55.16 Cr
EBITDA margin 15.2%
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹13.39 Cr
Issued & subscribed
Open charges
₹27.51 Cr
Satisfied ₹33.24 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
331
Provident fund records
About Geltec Private Limited
Data last updated:
Geltec Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2002PTC135200. Its GSTIN is 27AAACB1782H2ZR (Maharashtra). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹13.39 Cr. It was formerly known as Banner Pharmacaps (India) Private Limited. It is led by directors including Vikram Bodhraj Tannan and Vivek Vikram Tannan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor Capsulationservices Premises Sion – Trombay Road Deonar, Mumbai, Maharashtra, India – 400088.
As per the financials filed for FY 2025, the company reported a revenue of ₹362.73 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹38.33 Cr (net margin 10.6%) and EBITDA of ₹55.16 Cr (EBITDA margin 15.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 11% over five years.
The company has about 331 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Geltec. As per MCA filings, the company has open charges of ₹27.51 Cr and satisfied charges of ₹33.24 Cr on record. Court records list 9 cases involving the company, including 6 filed by the company and 3 filed against it; 1 case is pending. The company has 24 deals on record (22 secondary share transfers, 2 funding rounds), with disclosed funding of ₹30.4 Lakh; the latest was in September 2024. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 3 smaller; the largest is Beta Drugs Limited with revenue of ₹368.79 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 248 overdue payments to 57 micro and small suppliers.
Geltec Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0006871). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website geltec.in.
Company details
CIN U24230MH2002PTC135200
Registration Number 135200
Incorporation Date 28 April 1994
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0006871
Recognitions & Rankings of Geltec
Contact details
Geltec Private Limited's registered office is in Mumbai, Maharashtra. Its website is geltec.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st Floor Capsulationservices Premises Sion – Trombay Road Deonar, Mumbai, Maharashtra, India – 400088
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Geltec Private Limited, buy the company report.
Comprehensive company report
Geltec Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Geltec is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Geltec Private Limited, buy the company report.
Financials of Geltec Private Limited
FY 2025 filings availableGeltec Private Limited reported revenue of ₹362.73 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹362.73 Cr ▲ 7%
Net profit · FY 2025
₹38.33 Cr margin 10.6%
EBITDA · FY 2025
₹55.16 Cr margin 15.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 9%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▲ 19%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 7% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38.33 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.2% | ||||
| Net Profit Margin | 10.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Geltec Private Limited, buy the company report.
Board of directors of Geltec Private Limited
Geltec has 8 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikram Bodhraj Tannan Also directs: VT Executive Advisory LLP, Universal Nutriscience Private Limited, Capsulation Services Private Limited and 1 more | Director | 02 Sep 2002 | 24 Years 1 Months | Current |
| Vivek Vikram Tannan Also directs: Universal Nutriscience Private Limited, Capsulation Services Private Limited, Universal Medicare Private Limited and 4 more | Director | 02 Sep 2002 | 24 Years 1 Months | Current |
| Suresh Khanna Also directs: Dossier Solutions and Services LLP | Director | 18 Mar 2008 | 18 Years 7 Months | Current |
| Piyush Ranjan Also directs: Capsulation Services Private Limited | Director | 01 Jun 2023 | 3 Years 4 Months | Current |
| Preetika Vikram Tanan | Director | 12 Aug 2015 | 11 Years 2 Months | Current |
| Bharat Sumant Raut | Director | 04 Apr 2007 | 19 Years 6 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Geltec Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Beta Drugs Limited | ₹368.79 Cr (FY 2025) | 24.0% | Baddi, Himachal Pradesh, India | |||
| Brawn Laboratories Limited | ₹368.56 Cr (FY 2025) | 15.0% | Delhi, India | |||
| M. J. Biopharm Private Limited | ₹367.26 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India | |||
| Biochem Pharmaceutical Industries Limited Part IX | ₹366.61 Cr (FY 2016) | 15.0% | Ahmedabad, Gujarat, India | |||
| Kopran Research Laboratories Limited | ₹365.89 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Geltec Private Limitedthis company | ₹362.73 Cr (FY 2025) | ₹38.33 Cr | 10.6% | 7.0% | 331 | Mumbai, Maharashtra, India |
| Mepro Pharmaceuticals Private Limited | ₹356.46 Cr (FY 2025) | 20.0% | Surendra Nagar, Gujarat, India | |||
| Bharat Parenterals Limited | ₹352 Cr (FY 2025) | 32.0% | Vadodara, Gujarat, India | |||
| Geno Pharmaceuticals Private Limited | ₹349.47 Cr (FY 2025) | 14.0% | Goa, India |
To see the full peer comparison of Geltec Private Limited, buy the company report.
Auditor
Geltec Private Limited is audited by KALYANIWALLA & MISTRY LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KALYANIWALLA & MISTRY LLP | FY 2023 | 104607W/W100166 |
Shareholding
The shareholding of Geltec Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Geltec Private Limited, buy the company report.
Charges & borrowings
Open charges
₹27.51 Cr
Satisfied charges
₹33.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Jan 2023 | 100670071 | The Hongkong and Shanghai Banking Corporation Limited | ₹2.01 Cr | Open | |
| 13 Feb 2017 | 100081658 | Others | ₹12 Cr | Open | |
| 09 Mar 2015 | 10559015 | Kotak Mahindra Bank Limited | ₹13.5 Cr | Open | |
| 20 Jan 2020 | 100325008 | Citi Bank N.A. | ₹1 Cr | Satisfied | |
| 26 Mar 2010 | 10271972 | Dbs Bank Ltd | ₹5 Cr | Satisfied |
To see the full charge records of Geltec Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Geltec Private Limited has 24 deals on record (22 secondary share transfers, 2 funding rounds), with disclosed funding of ₹30.4 Lakh; the latest was in September 2024.
Total deals
24
Secondary share transfers
22
Funding rounds
2
Disclosed funding
₹30.4 Lakh
Deals on record (5 of 24)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Universal Medicare Private Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Universal Medicare Private Limited , Capsulation Services Private Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Seller: Universal Medicare Private Limited , Capsulation Services Private Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Universal Medicare Private Limited |
| Jan 2010 | Secondary share transfer | Undisclosed | Seller: Capsulation Services Private Limited |
To see the full deal history of Geltec Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Geltec Private Limited has 9 court cases on record: 6 filed by Geltec, 3 filed against it. 1 case is pending and 8 are disposed.
Total cases
9
Filed by the company
6
Filed against the company
3
Pending
1
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 3 | 1 |
| District courts | 2 | 0 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0104-Labour Matters : Matters relating to wages, bonus, ad-hoc, casual daily wages & their regularisation) | Filed by the company against North Karnataka Durgs and Pharmaceutical Manufacturers Welfare Association Represented by Its Hon.Secretary C/O Nandu Chemicals Pvt.Ltd., N-12, Industrial Estate Gokul Road Hubli-580 030 , , Karnataka and 19 others | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against Teh State of Karnataka Represented | Pending |
| District court, BENGALURU RURAL, Karnataka | Civil suit | Filed by the company against an individual | Disposed |
| District court, BENGALURU RURAL, Karnataka | Civil suit | Filed by the company against individuals | Disposed |
| High Court of Karnataka | Appeal | Filed against the company | Disposed |
To see the full case history of Geltec Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Geltec Private Limited was last rated by Crisil on 15 Apr 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 15 Apr 2021 |
To see the full credit ratings and regulatory alerts of Geltec Private Limited, buy the company report.
MSME payment delays
Geltec Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 248 overdue payments to 57 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 57)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Koel Colours Pvt Ltd | |||
| Amar Deo Plastic Industries | |||
| Chaitanya Agro-Bio-Tech Private Limited | |||
| an individual supplier | |||
| Singhvi Foils |
To see the full MSME payment records of Geltec Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Geltec has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Geltec Private Limited has a workforce of 331 employees on its EPFO records as of Apr 08, 2024, across 2 active EPFO establishments.
Employee count
331
Active EPFO establishments
2
Employee growth
-0.6%
GST
Geltec has 5 GST registrations: 4 active and 1 cancelled or inactive.
Total GSTINs
5
Active
4
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACB1782H2ZR | Maharashtra | Active | 06 Jul 2017 |
| 27AAACB1782H4ZP | Maharashtra | Active | 12 Aug 2017 |
| 24AAACB1782H1ZY | Gujarat | Active | 01 Jul 2017 |
| 29AAACB1782H1ZO | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Geltec Private Limited, buy the company report.
Recent activity
Geltec Private Limited has 18 board changes on record since 2002: 8 appointments and 10 cessations. The latest: Preetika Vikram Tanan ceased to be Director on 31 Jan 2024.
AGM
Geltec Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Geltec Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Preetika Vikram Tanan ceased to be Director.
Ceased
Piyush Ranjan ceased to be Additional Director.
Ceased
Vivek Vikram Tannan ceased to be Director.
Appointed
Piyush Ranjan was appointed as Director.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 2.01 Cr with Charge ID 100670071 was registered on 05 Jan 2023.
Charges
A charge registered on 20 Jan 2020 via Charge ID 100325008 with Citi Bank N.A. was fully satisfied on 25 Mar 2022.
Charges
A charge with Citi Bank N.A. amounted to Rs. 1.00 Cr with Charge ID 100325008 was registered on 20 Jan 2020.
Ceased
Kahan Chand Narang ceased to be Director.
Ceased
Gaurav Sharma ceased to be Director Appointed In Casual Vacancy.
Ceased
Satish Kumar Mehra ceased to be Director.
25 earlier events are in the company report.
Frequently asked questions
Geltec is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 1994 (32+ years old) and is registered under CIN U24230MH2002PTC135200.
Geltec has 8 current directors:
- Vikram Bodhraj Tannan - Director
- Vivek Vikram Tannan - Director
- Suresh Khanna - Director
- Piyush Ranjan - Director
- Preetika Vikram Tanan - Director
- Bharat Sumant Raut - Director
- Rakesh Khanna - Director
- Gaurav Sharma - Director
The latest financial statements of Geltec on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Geltec is 27AAACB1782H2ZR, registered in Maharashtra. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAACB1782H4ZP (Maharashtra), 24AAACB1782H1ZY (Gujarat), 29AAACB1782H1ZO (Karnataka).
The CIN (Corporate Identification Number) of Geltec is U24230MH2002PTC135200. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Geltec has 9 court cases on record: 6 filed by the company and 3 filed against it. 1 is pending. Most are in the high courts.
Geltec was incorporated on 28 April 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
Geltec has 24 deals on record (22 secondary share transfers, 2 funding rounds), with disclosed funding of ₹30.4 Lakh; the latest was in September 2024.
The peers of Geltec by revenue are Beta Drugs Limited, Brawn Laboratories Limited, M. J. Biopharm Private Limited, Biochem Pharmaceutical Industries Limited Part IX, Kopran Research Laboratories Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Preetika Vikram Tanan ceased to be Director on 31 Jan 2024. Piyush Ranjan ceased to be Additional Director on 29 Sep 2023. Vivek Vikram Tannan ceased to be Director on 30 Jun 2023. Geltec has 18 board changes on record in total.
Yes, Geltec is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0006871).
Geltec has 14 MSME Form 1 returns on record between 2019 and 2024, listing 248 overdue payments to 57 micro and small suppliers. The latest return was filed on 29 Apr 2024.